HomeIllumina defends $7.1 billion Grail buy to fend off antitrust regulatorsFILE PHOTO: The offices of gene sequencing company Illumina Inc

FILE PHOTO: The offices of gene sequencing company Illumina Inc

The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo

Most Read

Meta to lay off 5% of ‘lowest performers’, plans to hire for impacted roles

January 14, 2025

Apple’s new fees for app developers under fresh EU scrutiny, Bloomberg reports

January 13, 2025

Factbox-LA blaze damage likely to be largest wildfire insured loss in US history

January 13, 2025

Eli Lilly to buy Scorpion Therapeutics’ cancer therapy for up to $2.5 billion

January 13, 2025